Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer

✍ Scribed by Toshiki Kijima; Yasuhisa Fujii; Minato Yokoyama; Junichiro Ishioka; Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Fumitaka Koga; Hitoshi Masuda; Satoru Kawakami; Kazunori Kihara

• Book ID: 115199544
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 228 KB
• Volume: 110
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2012.10959.x